Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: Studying Macrophage-Epithelial Cell Interactions in Salivary Gland Regeneration After Injury
Published on: November 17, 2023
Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
Daisy A Hoagland1,2, Patricia Rodríguez-Morales1,2, Alexander O Mann1,2
1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Abstract:
Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. We found that macrophage-derived oncostatin M (OSM) counteracted the pathological effects of type I interferon (IFN-I) during infection and damage in mice. At baseline, OSM-deficient mice exhibited altered alveolar type II (ATII) epithelial cell states. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality. OSM delivery to the lung induced ATII proliferation and was sufficient to protect deficient mice against morbidity. Furthermore, OSM promoted organoid formation despite the growth-inhibitory effects of IFN-I. These findings identify OSM as an indispensable macrophage-derived growth factor that maintains the homeostasis of lung epithelial cells and promotes their proliferation to overcome IFN-I-mediated immunopathology.
Insights
Macrophage-derived oncostatin M (OSM) is crucial for lung repair after viral infection. OSM promotes epithelial cell growth, counteracting harmful type I interferon (IFN-I) responses and improving survival.
Area of Science:
- Immunology
- Cell Biology
- Pulmonary Medicine
Background:
- Restoring the lung epithelial barrier requires coordinated tissue repair and antiviral immunity.
- Type I interferons (IFN-I) are critical for antiviral defense but can impair tissue repair.
- The role of specific macrophage-derived factors in balancing these processes is not fully understood.
Purpose of the Study:
- To investigate the role of macrophage-derived oncostatin M (OSM) in lung epithelial repair following viral infection.
- To determine how OSM influences type I interferon (IFN-I) responses and epithelial cell homeostasis.
- To assess the therapeutic potential of OSM in mitigating infection-induced lung damage.
Main Methods:
- Utilized mouse models deficient in OSM.
- Administered influenza virus or viral mimics to induce infection and damage.
- Analyzed alveolar type II (ATII) epithelial cell states and proliferation.
- Assessed IFN-I responses, mortality, and morbidity.
- Evaluated OSM's effect on lung organoid formation in vitro.
Main Results:
- OSM-deficient mice showed altered ATII cell states at baseline.
- Lack of OSM led to heightened IFN-I responses and increased mortality after viral challenge.
- OSM administration induced ATII cell proliferation and protected deficient mice from morbidity.
- OSM promoted lung organoid formation, overcoming IFN-I-induced growth inhibition.
Conclusions:
- Oncostatin M (OSM) is an essential macrophage-derived growth factor for lung epithelial homeostasis.
- OSM counteracts the detrimental effects of type I interferon (IFN-I) during viral infections.
- OSM promotes epithelial cell proliferation, crucial for overcoming immunopathology and restoring lung function.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

